Identifying better medicines to deliver better care

Welcome to Animol Discovery. We are a biopharmaceutical company focused on discovering novel, active pharmaceutical ingredients to transform the outcomes for animal patients.

Animol is building its own pipeline of breakthrough proprietary veterinary small molecules, led by a team of animal health industry experts with vast experience in drug discovery and development. With our unique and powerful technology platform we deliver innovative medicines that are specifically designed for the needs of veterinary patients.

Identifying better medicines to deliver better care

Welcome to Animol Discovery. We are a biopharmaceutical company focused on identifying and developing next- generation antiparasitics and therapeutics to transform the outcomes for our animal patients.

Animol is building its own pipeline of break-through proprietary veterinary small molecules led by a team of animal health industry experts with vast experience in bringing drugs to market. With our unique and powerful technology platform we deliver innovative medicines that are specifically designed for the needs of veterinary patients.

Protecting animals from infectious diseases

Parasitic diseases remain a substantial threat to the wellbeing and health of our animals, ranging from allergies to severe life-threatening conditions. In addition, parasitic diseases are one of the most economically relevant causes of lost productivity in livestock. While great progress in the control of many parasites has been made over the past decades, many of these treatments have room for improvement and resistance against some of the most important and therefore most commonly used classes of antiparasitics are emerging. Animol Discovery strives to fill this gap by discovering novel active pharmaceutical ingredients to address unmet needs.

Protecting animals from parasitic disease

Parasitic diseases remain a substantial threat to the wellbeing and health of our animals, ranging from allergies to severe life-threatening conditions. In addition, parasitic diseases are one of the most economically relevant causes of lost productivity in livestock. While great progress in the control of many parasites has been made over the past decades, many of these treatments have room for improvement and resistance against some of the most important and therefore most commonly used classes of antiparasitics are emerging. Animol Discovery strives at filling this gap and delivering novel antiparasitic classes for unmet needs.

Tackling non-infectious and chronic diseases: meeting the distinct needs of our pets

In companion animals veterinary medicine has transitioned from short-term treatment of diseases towards long-term health management. Pet parents increasingly view their dog or cat as a family member that deserves a high level of medical care. Many of the existing treatments currently used in animal health have originated from experience in humans and were therefore not specifically designed for veterinary patients. Our distinctive platform allows us to explore treatment targets that are unique to diseases in animals and provide medicines that are tailored to the needs of our patients.

Novel therapeutics for the distinct needs of our companions

In companion animals veterinary medicine has transitioned from short-term treatment of diseases towards long-term health management. Pet parents increasingly view their dog or cat as a family member that deserves a high level of medical care. Many of the existing treatments currently used in animal health have originated from experience in humans and were therefore not specifically designed for veterinary patients. Our distinctive platform allows us to explore treatment targets that are unique to diseases in animals and provide medicines that are for the first time tailored to the needs of our patients.